Daejeon, South Korea

Doo-Sang Park

This inventor holds 6 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Korea Research Institute of Bioscience and Biotechnology, Healthbiome, Lactomason Co., Ltd.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doo-Sang Park. Retrieved from https://idiyas.com/inventor/doo-sang-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 50.0

 

Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Taejon-shi, KR (2007 - 2009)
  • Daejeon, KR (2012 - 2023)

Company Filing History:


Years Active: 2007-2026

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Doo-Sang Park: Innovator in Biotechnology

Introduction

Doo-Sang Park is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the areas of brain diseases and cardiovascular health. With a total of 6 patents, his work has the potential to impact various industries, including medicine and health.

Latest Patents

One of his latest patents involves a strain that has prophylactic or therapeutic effects on degenerative brain diseases. This invention provides a strain that may inhibit neuroinflammation and improve movement regulation, cognitive, and memory functions in animal models suffering from conditions like Parkinson's disease and Alzheimer's disease. The strain can be effectively utilized in foods, medicines, or feeds aimed at preventing or treating these brain diseases.

Another notable patent focuses on a novel quinoline compound and a composition containing centipede extract for the prevention and treatment of cardiovascular diseases. This invention highlights the potential of the quinoline compound and centipede extracts to exhibit excellent LDL-antioxidant activity and anti-inflammatory properties. These compounds can be included as effective ingredients in treatments for various cardiovascular conditions, including hyperlipidemia and atherosclerosis.

Career Highlights

Doo-Sang Park has worked with esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and Healthbiome. His research and innovations have positioned him as a key figure in the biotechnology sector.

Collaborations

Throughout his career, he has collaborated with notable colleagues, including Hyun-Woo Oh and Ho-Yong Park. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Doo-Sang Park's innovative work in biotechnology, particularly in addressing degenerative brain diseases and cardiovascular health, showcases his commitment to improving human health. His patents reflect a deep understanding of the complexities of these conditions and offer promising solutions for the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…